Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries: An Analysis of Patients Receiving Warfarin in the RE-LY Trial

Study Questions:

What is the relationship between warfarin dosing practice and time in therapeutic range (TTR) or outcomes in a clinical trial of warfarin for stroke prevention in atrial fibrillation?